Elibrin 5, 10 & 20 5 mg, 10 mg, 20 mg Tablets
PDF Leaflet Revision Date: 10 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive disorder and relapse prevention.
Dosage (summary)
Adults: Start at 10 mg once daily, may adjust 5-20 mg. Elderly: Start at 5 mg daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Avoid in pregnancy; safety during breastfeeding not established.
Key Drug Interactions
- MAOIs
- CYP2D6 inhibitors
- CYP450 inducers
Contraindications
- Hypersensitivity to vortioxetine
- Concomitant use with MAOIs
Common side effects
- Nausea
- Dizziness
- Decreased appetite
Counselling Points
- Monitor for suicidal thoughts
- Avoid abrupt discontinuation
- Caution with driving
Serious warnings
- Risk of suicidal thoughts
- Seizures
- Serotonin syndrome
Important Disclaimer
The Elibrin 5, 10 & 20 5 mg, 10 mg, 20 mg Tablets professional information leaflet below is the property of Zydus Healthcare Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
